Pfizer has a pipeline with more than 90 drugs in development. Pfizer is developing two drugs capable of generating more than a billion sales. Competition is fierce but Pfizer is in the race.
EOM Pharmaceutical has filed to raise $25m in an IPO, primarily for product development and to repay an outstanding note. Click here for details on the EOM IPO.
Eye drug developer Belite Bio (BLTE) stock soared 160% following its $36M initial public offering. Shares of BLTE opened at $12.50 after pricing at $6 per American Depositary Share